FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4362468665> ?p ?o ?g. }

• W4362468665 endingPage "e33416" @default.
• W4362468665 startingPage "e33416" @default.
• W4362468665 abstract "Triple-negative breast cancer (TNBC) is associated with younger age and worse long-term survival. However, the characteristics and prognosis of different subtypes of breast cancer (BC) in young (<40 years) patients have not yet been elucidated. The present population-based study explored the clinical and pathological characteristics of young TNBC patients and investigated their long-term survival. We enrolled patients from the Surveillance, Epidemiology, and End Results database younger than 40 years of age with primary BC. Cases were defined as patients with TNBC (hormone receptor [HR]−/human epidermal growth factor receptor 2 [HER2]−), and controls were patients with other subtypes of BC (HR−/HER2+, HR+/HER2−, and HR+/HER2+). Demographic, pathological, and radiotherapy, chemotherapy, and surgery data were extracted and the overall survival was the primary endpoint. We enrolled 14,234 young patients with BC in the present study, of whom 2798 (19.7%) had TNBC and 11,436 (80.3%) had another BC subtype. A higher proportion of TNBC patients than non-TNBC patients had a more advanced tumor-node-metastasis stage (II–IV 80.5% vs 73.1%, P < .001), and smaller proportions underwent radiotherapy (50.0% vs 53.3%, P = .002) and surgery (91.8% vs 92.9%, P < .001). TNBC was associated with significantly lower 5-year survival rates than other subtypes among patients with regional node positivity (0, 1–3, 4–9, ≥10: 54.2% vs 57.7%, 44.2% vs 55.9%, 31.0% vs 52.0%, and 27.7% vs 38.8%, P < .001) and those with different lymph node ratios (low, intermediate, high: 50.9% vs 56.0%, 34.6% vs 53.6%, and 24.8% vs 44.8%, P < .001). Our research is the first to investigate the relevant characteristics of young TNBC patients in comparison with those of young non-TNBC patients based on the surveillance, epidemiology, and end results database. We found that young TNBC patients have a higher pathological stage and worse long-term survival than young patients with other BC subtypes. These findings have implications in identifying young patients with TNBC for aggressive therapy and further investigations should be performed to explore new multimodal treatments for such patients." @default.
• W4362468665 created "2023-04-05" @default.
• W4362468665 creator A5008659449 @default.
• W4362468665 creator A5077604881 @default.
• W4362468665 creator A5083270442 @default.
• W4362468665 creator A5087446982 @default.
• W4362468665 date "2023-03-31" @default.
• W4362468665 modified "2023-10-18" @default.
• W4362468665 title "Prognostic disparities in young patients based on breast cancer subtype: A population-based study from the SEER database" @default.
• W4362468665 cites W1951863703 @default.
• W4362468665 cites W1972098018 @default.
• W4362468665 cites W1991977204 @default.
• W4362468665 cites W1992387129 @default.
• W4362468665 cites W1995224853 @default.
• W4362468665 cites W2019109147 @default.
• W4362468665 cites W2019495648 @default.
• W4362468665 cites W2043711125 @default.
• W4362468665 cites W2067245120 @default.
• W4362468665 cites W2082326948 @default.
• W4362468665 cites W2095233665 @default.
• W4362468665 cites W2106066649 @default.
• W4362468665 cites W2106428582 @default.
• W4362468665 cites W2115999357 @default.
• W4362468665 cites W2123736303 @default.
• W4362468665 cites W2139269097 @default.
• W4362468665 cites W2159238482 @default.
• W4362468665 cites W2161426850 @default.
• W4362468665 cites W2165285899 @default.
• W4362468665 cites W2493148753 @default.
• W4362468665 cites W2555381365 @default.
• W4362468665 cites W2794093676 @default.
• W4362468665 cites W2800980377 @default.
• W4362468665 cites W2886058220 @default.
• W4362468665 cites W2917837889 @default.
• W4362468665 cites W2954762607 @default.
• W4362468665 cites W3003463594 @default.
• W4362468665 cites W3010333843 @default.
• W4362468665 cites W3045159338 @default.
• W4362468665 cites W3097445198 @default.
• W4362468665 cites W3128877721 @default.
• W4362468665 cites W4296502916 @default.
• W4362468665 cites W609467180 @default.
• W4362468665 doi "https://doi.org/10.1097/md.0000000000033416" @default.
• W4362468665 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37000095" @default.
• W4362468665 hasPublicationYear "2023" @default.
• W4362468665 type Work @default.
• W4362468665 citedByCount "0" @default.
• W4362468665 crossrefType "journal-article" @default.
• W4362468665 hasAuthorship W4362468665A5008659449 @default.
• W4362468665 hasAuthorship W4362468665A5077604881 @default.
• W4362468665 hasAuthorship W4362468665A5083270442 @default.
• W4362468665 hasAuthorship W4362468665A5087446982 @default.
• W4362468665 hasBestOaLocation W43624686651 @default.
• W4362468665 hasConcept C107130276 @default.
• W4362468665 hasConcept C121608353 @default.
• W4362468665 hasConcept C126322002 @default.
• W4362468665 hasConcept C143998085 @default.
• W4362468665 hasConcept C146357865 @default.
• W4362468665 hasConcept C151730666 @default.
• W4362468665 hasConcept C203092338 @default.
• W4362468665 hasConcept C205545832 @default.
• W4362468665 hasConcept C207103383 @default.
• W4362468665 hasConcept C207886595 @default.
• W4362468665 hasConcept C2780110267 @default.
• W4362468665 hasConcept C2908647359 @default.
• W4362468665 hasConcept C44249647 @default.
• W4362468665 hasConcept C509974204 @default.
• W4362468665 hasConcept C530470458 @default.
• W4362468665 hasConcept C535046627 @default.
• W4362468665 hasConcept C71924100 @default.
• W4362468665 hasConcept C86803240 @default.
• W4362468665 hasConcept C99454951 @default.
• W4362468665 hasConceptScore W4362468665C107130276 @default.
• W4362468665 hasConceptScore W4362468665C121608353 @default.
• W4362468665 hasConceptScore W4362468665C126322002 @default.
• W4362468665 hasConceptScore W4362468665C143998085 @default.
• W4362468665 hasConceptScore W4362468665C146357865 @default.
• W4362468665 hasConceptScore W4362468665C151730666 @default.
• W4362468665 hasConceptScore W4362468665C203092338 @default.
• W4362468665 hasConceptScore W4362468665C205545832 @default.
• W4362468665 hasConceptScore W4362468665C207103383 @default.
• W4362468665 hasConceptScore W4362468665C207886595 @default.
• W4362468665 hasConceptScore W4362468665C2780110267 @default.
• W4362468665 hasConceptScore W4362468665C2908647359 @default.
• W4362468665 hasConceptScore W4362468665C44249647 @default.
• W4362468665 hasConceptScore W4362468665C509974204 @default.
• W4362468665 hasConceptScore W4362468665C530470458 @default.
• W4362468665 hasConceptScore W4362468665C535046627 @default.
• W4362468665 hasConceptScore W4362468665C71924100 @default.
• W4362468665 hasConceptScore W4362468665C86803240 @default.
• W4362468665 hasConceptScore W4362468665C99454951 @default.
• W4362468665 hasIssue "13" @default.
• W4362468665 hasLocation W43624686651 @default.
• W4362468665 hasLocation W43624686652 @default.
• W4362468665 hasLocation W43624686653 @default.
• W4362468665 hasLocation W43624686654 @default.
• W4362468665 hasOpenAccess W4362468665 @default.
• W4362468665 hasPrimaryLocation W43624686651 @default.

• next